ZINNAT 1.5 g, powder for solution for infusion bottle
Active ingredients: Cefuroxime, Cefuroxime sodium
Commercialized according to BDPMDispensing in France: Prescription only
Powder for solution for infusionbottleintramusculaire;intraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ZINNAT 1,5 g, poudre pour solution pour perfusion
- Pharmaceutical form
- poudre pour solution pour perfusion
- Route of administration
- intramusculaire;intraveineuse
- Presentation description
- 1 flacon(s) en verre
- Marketing authorisation holder
- SANDOZ
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 21 Jun 2023
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
64292072CIP73500890CIP133400935008909Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CÉFUROXIME SODIQUEpoudre | — | SA |
| CÉFUROXIMEpoudre | 1,5 g · un flacon de poudre | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.